Voltar
Artigo Revisado por pares
BIBTEX RIS

Cantuzumab mertansine in a three-times a week schedule: a phase I and pharmacokinetic study

2008; Springer Science+Business Media; Volume: 62; Issue: 5 Linguagem: Inglês

10.1007/s00280-007-0672-8

ISSN

1432-0843

Autores

Jordi Rodón, Mitchell Garrison, Lisa A. Hammond, Johann S. de Bono, Lon Smith, Leonardo Forero, Desirée Hao, Chris H. Takimoto, John M. Lambert, Lini Pandite, Maria Howard, Hongsheng Xie, Anthony W. Tolcher,

Tópico(s)

CAR-T cell therapy research

Referência(s)